The Patent Finder

Asta Medica Aktiengesellschaft

Also on record
Records under this name other than patents Asta Medica Aktiengesellschaft holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Asta Medica Aktiengesellschaft

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,538,151Modifications of 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonylaminobenzene, and processes for their preparation
Formerly held
Term ended
Term ended Dec 6, 2023 · USPTO record
Term endedTerm ended Dec 6, 2023USPTO record
US 6,667,058Oral forms of administration containing solid flupirtine with controlled release of active substance
Formerly held
Term ended
Term ended Nov 25, 2022 · USPTO record
Term endedTerm ended Nov 25, 2022USPTO record
US 6,828,415Oligopeptide lyophilisate, their preparation and use
Formerly held
Term ended
Term ended Dec 7, 2021 · USPTO record
Term endedTerm ended Dec 7, 2021USPTO record
US 8,820,321Storage System for Powdered Pharmaceuticals, and Inhaler Equipped with This System
Formerly held
Term ended
Term ended Jul 10, 2021 · Medium confidence
Term endedTerm ended Jul 10, 2021Medium confidence
US 6,436,924Antihistamine leukotriene combinations
Formerly held
Term ended
Term ended Feb 15, 2021 · USPTO record
Term endedTerm ended Feb 15, 2021USPTO record
US 7,234,464Storage system for powdered pharmaceuticals, and inhaler equipped with this system
Formerly held
Term ended
Term ended Dec 18, 2020 · USPTO record
Term endedTerm ended Dec 18, 2020USPTO record
US 6,545,039Facilitated administration of &agr;-lipoic acid or derivatives thereof
Formerly held
Term ended
Term ended Nov 9, 2020 · USPTO record
Term endedTerm ended Nov 9, 2020USPTO record
US 6,251,935Treatment of migraine by administration of .alpha.-lipoic acid or derivatives thereof
Formerly held
Term ended
Term ended Aug 15, 2020 · USPTO record
Term endedTerm ended Aug 15, 2020USPTO record
US 6,630,157Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides
Formerly held
Term ended
Term ended Aug 15, 2020 · USPTO record
Term endedTerm ended Aug 15, 2020USPTO record
US 6,627,609LHRH antagonists having improved solubility properties
Formerly held
Term ended
Term ended Mar 14, 2020 · USPTO record
Term endedTerm ended Mar 14, 2020USPTO record
10 of 174 patents shown.
Pro members see all 174.
Pro members: see all 174 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited